Alliance Releases Statement on Legislation Suspending Medical Device Excise Tax
Published December 15, 2017
December 15th 2017 – The Alliance for Aging Research’s President and CEO Susan Peschin, MHS, has issued the following statement regarding H.R. 4617, which will provide a temporary moratorium on the medical device excise tax through 2022.
The Alliance applauds the introduction of H.R. 4617 by the House Ways and Means Committee to extend the suspension of the medical device excise tax through 2022. We also encourage Congress to pass this legislation without delay. We support policies that advance medical research and innovation, particularly when they address the needs of aging patients. We believe the medical device excise tax stifles innovation because it places a limiting effect on the critical resources companies can devote to research and development of vital new medical devices. These medical devices help improve detection and treatment of age-related diseases and conditions that affect the health and quality of life of the aging population.
About the Alliance for Aging Research
The Alliance for Aging Research is the leading nonprofit organization dedicated to accelerating the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health. The Alliance believes advances in research help people live longer, happier, more productive lives and reduce healthcare costs over the long term. For more than 30 years, the Alliance has guided efforts to substantially increase funding and focus for aging at the National Institutes of Health and Food and Drug Administration; built influential coalitions to guide groundbreaking regulatory improvements for age-related diseases; and created award-winning, high-impact educational materials to improve the health and well-being of older adults and their family caregivers. For more information, visit www.agingresearch.org
Media Contact:
Janelle Germanos
Communications Manager
[email protected]
(202) 688-1209